Predict your next investment

Cygnal Therapeutics company logo
HEALTHCARE | Biotechnology
cygnaltx.com

See what CB Insights has to offer

Founded Year

2017

Stage

Series B | Alive

Total Raised

$65M

Last Raised

$65M | 2 yrs ago

About Cygnal Therapeutics

Cygnal Therapeutics is building a platform to develop drugs in the field of exoneural biology. Exoneural biology is broadly implicated in human health and disease. Fueled by its Exoneural Medicine Platform, it is creating new medicines across multiple therapeutic areas, starting with cancer and inflammatory diseases.

Cygnal Therapeutics Headquarter Location

Biomed Parking Lot 325 Vassar Street

Cambridge, Massachusetts, 02139,

United States

877-441-4374

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Cygnal Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Cygnal Therapeutics is included in 2 Expert Collections, including Biopharmaceuticals.

B

Biopharmaceuticals

5,881 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

C

Cancer

3,604 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

Cygnal Therapeutics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Cygnal Therapeutics Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.